Rouba Kozak

Company: Novartis AG

Job title: Global Biomarker & Diagnostics Leader of Neuroscience

Seminars:

Precision Medicine Approaches as the Next Step to Account for Alzheimer’s & Parkinson’s Disease Heterogeneity & Patient Specificity 3:30 pm

Harnessing multi-omic and GWAS data to identify the range of genetic markers and risk factors contributing to the heterogeneity of Alzheimer’s and Parkinson’s disease Strategizing on how personalized treatment plans targeting specific disease subtypes and characteristics can optimize effectiveness of interventions and slow disease progression Highlighting the potential of precision medicine to bridge the gap…Read more

day: Conference Day Two